Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-02-19
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale+OE$22.33-3,15946,841-6%-$70,552
2020-02-18
SGENSeattle Genetics Inc /waDansey Roger DChief Medical OfficerS - Sale$116.33-350107,6590%-$40,716
M
2020-02-18
MGTXMeiragtx Holdings PlcNaylor StuartChief Development OfficerS - Sale$17.96-12,000486,017-2%-$215,512
M
2020-02-18
KRYSKrystal Biotech, Inc.Krishnan Krish SPres, CEO, 10%S - Sale$62.06-50,0004,050,086-1%-$3,102,896
D
2020-02-18
HARPHarpoon Therapeutics, Inc.Sacks NatalieChief Medical OfficerS - Sale+OE$15.00-1,52145,754-3%-$22,815
M
2020-02-18
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$32.91-14,34142,825-25%-$472,006
2020-02-18
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$32.56-16,4595,068-76%-$535,905
D
2020-02-18
ADVMAdverum Biotechnologies, Inc.Gasmi MehdiDirS - Sale+OE$16.23-5,000258,979-2%-$81,156
D
2020-02-19
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale+OE$33.00-80,0000-100%-$2,640,000
DM
2020-02-18
ADPTAdaptive Biotechnologies CorpRobins Harlan SChief Scientific OfficerS - Sale+OE$31.76-25,900870,679-3%-$822,679
M
2020-02-18
TWSTTwist Bioscience CorpWeiss PatrickCOOS - Sale$30.09-5,83274,037-7%-$175,462
2020-02-18
TWSTTwist Bioscience CorpBanyai WilliamSee RemarksS - Sale$30.71-11,000611,033-2%-$337,777
2020-02-18
WINTWindtree Therapeutics Inc /de/Huang JamesDir, 10%P - Purchase$3.84+4006,417,2180%+$1,535
D
2020-02-18
CHRSCoherus Biosciences, Inc.Anicetti Vincent RCOOS - Sale+OE$21.64-10,00052,996-16%-$216,390
2020-02-14
MNTAMomenta Pharmaceuticals IncCarvajal AlejandraGCS - Sale$31.54-6,8920-100%-$217,374
D
2020-02-14
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$32.00-21,894522,400-4%-$700,608
2020-02-13
BLUEBluebird Bio, Inc.Baird William D IIICFOS - Sale$90.60-1,25413,746-8%-$113,612
D
2020-02-14
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale+OE$33.63-20,00050,050-29%-$672,564
DM
2020-02-14
NSTGNanostring Technologies IncBrown J. ChadSVP, Sales, MarketingS - Sale+OE$32.29-7,56010,255-42%-$244,122
2020-02-14
ALECAlector, Inc.King RobertChief Development OfficerS - Sale$29.56-15,000492,317-3%-$443,376
2020-02-14
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale$29.54-10,000263,719-4%-$295,390
2020-02-14
MRNAModerna, Inc.Sagan PaulDirP - Purchase$19.00+52,631514,060+11%+$999,989
2020-02-14
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$19.02-11,04624,659,4200%-$210,095
D
2020-02-18
RVMDRevolution Medicines, Inc.Flynn James EPossible Member of 10% Group, 10%P - Purchase$17.00+600,0002,096,384+40%+$10,200,000
AD
2020-01-08
ADPTAdaptive Biotechnologies CorpTaylor Stacy LSVP, GCS - Sale+OE$30.00-6621,300-34%-$19,860
D
2020-02-13
ADPTAdaptive Biotechnologies CorpRobins Chad MCEO, COBS - Sale+OE$31.56-11,1202,728,1800%-$350,947
2020-02-14
ADVMAdverum Biotechnologies, Inc.Scopa James PaulDirP - Purchase$13.75+10,00030,000+50%+$137,500
D
2020-02-12
ADVMAdverum Biotechnologies, Inc.Gasmi MehdiDirS - Sale+OE$15.07-10,000258,979-4%-$150,690
2020-02-12
AVROAvrobio, Inc.Mackay GeoffreySee RemarksS - Sale$29.07-1,400490,3310%-$40,692
D
2020-02-13
MNTAMomenta Pharmaceuticals IncArroyo SantiagoSVP, Chief Medical OfficerS - Sale+OE$30.03-7,68919,576-28%-$230,901
D
2020-02-13
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale+OE$30.03-13,35657,166-19%-$401,108
D
2020-02-13
MNTAMomenta Pharmaceuticals IncKwon YoungChief Financial, Bus. OfficerS - Sale+OE$30.03-9,016130,103-6%-$270,750
DM
2020-02-13
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale+OE$30.17-9,33021,527-30%-$281,442
D
2020-02-13
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale+OE$30.03-6,68912,143-36%-$200,871
DM
2020-02-12
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$31.56-7,359522,400-1%-$232,256
D
2020-02-13
MNTAMomenta Pharmaceuticals IncCarvajal AlejandraGCS - Sale+OE$30.03-3,1086,892-31%-$93,333
2020-02-13
XLRNAcceleron Pharma IncKango SujayEVP, Chief Commercial OfficerS - Sale$94.10-59515,344-4%-$55,987
M
2020-02-12
MRNAModerna, Inc.Hoge StephenPresS - Sale$19.34-10,0002,070,6460%-$193,350
D
2020-02-12
TECHBio-Techne CorpHiggins John LDirS - Sale+OE$205.23-5,0004,021-55%-$1,026,133
2020-02-12
REPLReplimune Group, Inc.Coffin RobertPres, Chief Res, Dev OfficerS - Sale$17.04-48,5002,218,118-2%-$826,198
D
2020-02-11
NSTGNanostring Technologies IncBrown J. ChadSVP, Sales, MarketingS - Sale+OE$32.00-16,50110,255-62%-$528,032
D
2020-02-11
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale+OE$31.87-20,00050,050-29%-$637,368
D
2020-02-12
NSTGNanostring Technologies IncMalloy KirkDirS - Sale+OE$31.18-2,5000-100%-$77,950
DM
2020-02-11
ADPTAdaptive Biotechnologies CorpRobins Chad MCEO, COBS - Sale+OE$31.24-22,2402,728,180-1%-$694,778
D
2020-02-10
GILDGilead Sciences IncPletcher Brett AEVP,Corp Affairs, GCS - Sale+OE$69.32-2,95024,690-11%-$204,494
D
2020-02-10
ADPTAdaptive Biotechnologies CorpCohen Chad MCFOS - Sale+OE$31.52-20,0001,000-95%-$630,308
D
2020-02-11
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$32.09-37,075519,006-7%-$1,189,735
D
2020-02-10
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$114.61-28,472758,784-4%-$3,263,110
DM
2020-02-10
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale+OE$31.46-27,89188,935-24%-$877,520
2020-02-11
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$32.23-1125,857-2%-$3,610
2020-02-11
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$32.23-3501,332-21%-$11,281
2020-02-11
MNTAMomenta Pharmaceuticals IncKwon YoungChief Financial, Bus. OfficerS - Sale$32.23-350111,6190%-$11,281
DM
2020-02-10
RGNXRegenxbio Inc.Simpson CurranSVP, Product Development, CTOS - Sale+OE$50.28-56,9933,948-94%-$2,865,636
D
2020-02-10
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale+OE$50.07-14,806210,215-7%-$741,352
D
2020-02-10
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale+OE$50.11-24,8000-100%-$1,242,728
M
2020-02-10
WINTWindtree Therapeutics Inc /de/Fraser CraigPres, CEOP - Purchase$4.10+50064,031+1%+$2,050
2020-02-07
MRNAModerna, Inc.Kim Lorence H.CFOS - Sale$23.06-33,2951,302,510-2%-$767,783
M
2020-02-07
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$22.65-33,13415,968,4630%-$750,582
2020-02-11
AVROAvrobio, Inc.Paige ChristopherDirS - Sale$28.00-15,000252,512-6%-$420,000
2020-02-11
AVROAvrobio, Inc.Mackay GeoffreySee RemarksS - Sale$27.57-63,000491,731-11%-$1,737,081
2020-02-07
NBIXNeurocrine Biosciences IncRoberts EiryChief Medical OfficerS - Sale$103.31-1,6237,452-18%-$167,675
DM
2020-02-07
NBIXNeurocrine Biosciences IncLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$104.52-29,98423,200-56%-$3,133,912
2020-02-07
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale$103.32-1,52224,124-6%-$157,247
2020-02-07
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$103.31-1,218111,682-1%-$125,833
2020-02-07
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale$103.36-3,248432,357-1%-$335,696
2020-02-07
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale$103.33-1,62391,975-2%-$167,710
2020-02-07
NBIXNeurocrine Biosciences IncCooke JulieCHROS - Sale$103.26-9134,643-16%-$94,276
2020-02-07
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$103.33-1,623146,641-1%-$167,702
2020-02-07
NBIXNeurocrine Biosciences IncBenevich EricChief Commercial OfficerS - Sale$103.32-2,03020,087-9%-$209,747
2020-02-07
NBIXNeurocrine Biosciences IncAbernethy MattCFOS - Sale$103.35-2,0305,701-26%-$209,807
D
2020-02-10
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale+OE$31.50-2131,682-11%-$6,710
DM
2020-02-07
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale+OE$31.14-3,29689,051-4%-$102,640
DM
2020-02-07
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$31.83-7,491520,779-1%-$238,425
D
2020-02-10
GILDGilead Sciences IncWilson Gayle EDirS - Sale+OE$67.72-21,720126,782-15%-$1,470,878
D
2020-02-10
MNTAMomenta Pharmaceuticals IncKwon YoungChief Financial, Bus. OfficerS - Sale+OE$31.50-408111,9690%-$12,852
D
2020-02-10
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale+OE$31.50-2245,969-4%-$7,056
2020-02-07
ALECAlector, Inc.Oney SabahChief Business OfficerS - Sale$35.03-19,900573,918-3%-$697,097
2020-02-10
LIFEAtyr Pharma IncSchimmel PaulDirP - Purchase$4.25+254,000503,503+102%+$1,079,500
2020-02-11
ADMAAdma Biologics, Inc.Guiheen Lawrence P.DirP - Purchase$3.50+20,00071,000+39%+$70,000
2020-02-11
ADMAAdma Biologics, Inc.Mond JamesCSO, CMOP - Purchase$3.50+4,28522,174+24%+$14,998
2020-02-11
ADMAAdma Biologics, Inc.Grossman Jerrold BDirP - Purchase$3.50+45,714225,571+25%+$159,999
2020-02-11
ADMAAdma Biologics, Inc.Lenz BrianEVP, CFOP - Purchase$3.50+7,14232,142+29%+$24,997
2020-02-11
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOP - Purchase$3.50+85,7141,525,499+6%+$299,999
2020-02-11
ADMAAdma Biologics, Inc.Perceptive Advisors LLC10%P - Purchase$3.50+4,563,70016,084,802+40%+$15,972,950
2020-02-06
AMGNAmgen IncWilliams R SandersDirS - Sale$233.72-4254,988-8%-$99,331
D
2020-02-06
TWSTTwist Bioscience CorpWeiss PatrickCOOS - Sale+OE$28.16-7,68079,869-9%-$216,253
2020-02-06
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Tech. Operations OfficerS - Sale$14.21-4,11753,881-7%-$58,503
2020-02-06
ATRAAtara Biotherapeutics, Inc.Koppikar UtpalCFOS - Sale$14.21-1,78172,282-2%-$25,308
DM
2020-02-06
GILDGilead Sciences IncPletcher Brett AEVP,Corp Affairs, GCS - Sale+OE$68.58-6,42624,690-21%-$440,721
DM
2020-02-06
GILDGilead Sciences IncWold Olsen PerDirS - Sale+OE$68.55-42,00297,854-30%-$2,879,063
DM
2020-02-06
ALECAlector, Inc.Yu CalvinVP, FinanceS - Sale+OE$35.02-26,654110,686-19%-$933,371
D
2020-02-07
EDITEditas Medicine, Inc.Albright CharlesChief Scientific OfficerS - Sale+OE$26.95-62231,524-2%-$16,763
A
2019-12-23
ADVMAdverum Biotechnologies, Inc.Patterson Leone DCEO, Pres, DirS - Sale$10.72-40,000150,220-21%-$428,800
2020-02-07
PTEPolarityte, Inc.Hague RichardCOOS - Sale$3.02-12,950321,895-4%-$39,109
2020-02-07
PTEPolarityte, Inc.Mann Paul ElliotCFOS - Sale$3.02-12,833440,393-3%-$38,756
2020-02-07
PTEPolarityte, Inc.Hoyler Cameron J.Gen. Counsel, EVPS - Sale$3.04-11,667327,556-3%-$35,468
2020-02-07
PTEPolarityte, Inc.Seaburg David BPresS - Sale$3.02-16,333372,701-4%-$49,326
2020-02-06
AMGNAmgen IncPiacquad DavidSVP, Business DevelopmentS - Sale$229.93-9,26439,700-19%-$2,130,079
D
2020-02-05
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale+OE$32.10-10,000273,719-4%-$321,000
D
2020-02-07
LIFEAtyr Pharma IncShukla SanjayPres, CEOS - Sale+OE$4.03-7451,291-37%-$3,002
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top